Dr. Carr’s research is focused on developing quantitative imaging phenotypes and biomarkers applicable to population-based and personalized medicine. His current research is using advanced computed tomography (CT) techniques to measure coronary blood vessels, coronary plaque and the surrounding pericardial adipose tissue (fat cells) as a means to better understand who is at highest risk for myocardial infarction (heart attacks) and heart failure later in life (NIH-NHLBI 7R01HL098445-05). Dr. Carr is a member of the Vanderbilt University Imaging Institute of Imaging Science (VUIIS) and Vanderbilt Translational and Clinical Cardiovascular Research Center (VTRACC).